The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Citrate anticoagulation for continuous venovenous hemofiltration*
Abstract
OBJECTIVE: Continuous venovenous hemofiltration (CVVH) is applied in critically ill patients with acute renal failure for renal replacement. Heparins used to prevent circuit clotting may cause bleeding. Regional anticoagulation with citrate reduces bleeding, but has metabolic risks. The aim was to compare the safety and efficacy of the two. DESIGN: Randomized, nonblinded, controlled single-center trial. SETTING: General intensive care unit of a teaching hospital. PATIENTS: Adult critically ill patients needing CVVH for acute renal failure and without an increased bleeding risk. INTERVENTIONS: Regional anticoagulation with citrate or systemic anticoagulation with the low-molecular weight heparin nadroparin. MEASUREMENTS AND MAIN RESULTS: End points were adverse events necessitating discontinuation of study anticoagulant, transfusion, metabolic and clinical outcomes, and circuit survival. Of the 215 randomized patients, 200 received CVVH per protocol (97 citrate and 103 nadroparin). Adverse events required discontinuation of citrate in two patients (accumulation and clotting) of nadroparin in 20 (bleeding and thrombocytopenia) (p < 0.001). Bleeding occurred in 6 vs. 16 patients (p = 0.08). The median number of red blood cell units transfused per CVVH day was 0.27 (interquartile range, 0.0-0.63) for citrate, 0.36 (interquartile range, 0-0.83) for nadroparin (p = 0.31). Citrate conferred less metabolic alkalosis (p = 0.001) and lower plasma calcium (p < 0.001). Circuit survival was similar. Three-month mortality on intention-to-treat was 48% (citrate) and 63% (nadroparin) (p = 0.03), per protocol 45% and 62% (p = 0.02). Citrate reduced mortality in surgical patients (p = 0.007), sepsis (p = 0.01), higher Sepsis-Related Organ Failure Assessment score (p = 0.006), and lower age (p = 0.009). CONCLUSIONS: The efficacy of citrate and nadroparin anticoagulation for CVVH was similar, however, citrate was safer. Unexpectedly, citrate reduced mortality. Less bleeding could only partly explain this benefit, less clotting could not. Post hoc citrate appeared particularly beneficial after surgery, in sepsis and severe multiple organ failure, suggesting interference with inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L., Palevsky, P., & workgroup, T. A. (2004) · Critical Care · doi:10.1186/cc2872 · Cited by 6,781
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Calcium signalling: dynamics, homeostasis and remodelling
Berridge, M. J., Bootman, M. D., & Roderick, H. L. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1155 · Cited by 5,585
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
Ronco, C., Bellomo, R., Homel, P., Brendolan, A., Dan, M., Piccinni, P., & La Greca, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02430-2 · Cited by 1,594
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
The key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Substrate availability is a crucial regulator of the citric acid cycle, a central pathway recovering energy and maintaining redox state (37).”
BackgroundMetnitz, P. G. H., Krenn, C. G., Steltzer, H., Lang, T., Ploder, J., Lenz, K., Le Gall, J.-R., & Druml, W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200209000-00016 · Cited by 919
Bouman, C. S. C., Oudemans-van Straaten, H. M., Tijssen, J. G. P., Zandstra, D. F., & Kesecioglu, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200210000-00005 · Cited by 659
Self-citationInflammation, endothelium, and coagulation in sepsis
Schouten, M., Wiersinga, W. J., Levi, M., & van der Poll, T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607373 · Cited by 629
Extracellular calcium sensing and signalling
Hofer, A. M., & Brown, E. M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1154 · Cited by 612
Uchino, S., Bellomo, R., Morimatsu, H., Morgera, S., Schetz, M., Tan, I., Bouman, C., Macedo, E., Gibney, N., Tolwani, A., et al. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0754-4 · Cited by 555
Self-citationSaudan, P., Niederberger, M., De Seigneux, S., Romand, J., Pugin, J., Perneger, T., & Martin, P. Y. (2006) · Kidney International · doi:10.1038/sj.ki.5001705 · Cited by 440
Monchi, M., Berghmans, D., Ledoux, D., Canivet, J.-L., Dubois, B., & Damas, P. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2047-x · Cited by 369
Kutsogiannis, D. J., Gibney, R. T. N., Stollery, D., & Gao, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00342.x · Cited by 294
Brophy, P. D., Somers, M. J. G., Baum, M. A., Symons, J. M., McAfee, N., Fortenberry, J. D., Rogers, K., Barnett, J., Blowey, D., Baker, C., et al. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh817 · Cited by 214
Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass
Jansen, N. J. G., van Oeveren, W., Broek, L. V. D., Oudemans-van Straaten, H. M., Stoutenbeek, C. P., Joen, M. C. N., Roozendaal, K. J., Eysman, L., & Wildevuur, C. R. H. (1991) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(20)31421-5 · Cited by 203
Self-citationvan de Wetering, J., Westendorp, R. G., van der Hoeven, J. G., Stolk, B., Feuth, J. D., & Chang, P. C. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v71145 · Cited by 202
Gritters, M., Grooteman, M. P. C., Schoorl, M., Schoorl, M., Bartels, P. C. M., Scheffer, P. G., Teerlink, T., Schalkwijk, C. G., Spreeuwenberg, M., & Nubé, M. J. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi069 · Cited by 161
Platelet Count Monitoring and Laboratory Testing for Heparin-Induced Thrombocytopenia
Warkentin, T. E. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1415-pcmalt · Cited by 142
Reeves, J. H., Cumming, A. R., Gallagher, L., O'Brien, J. L., & Santamaria, J. D. (1999) · Critical Care Medicine · doi:10.1097/00003246-199910000-00026 · Cited by 135
Betjes, M. G. H., van Oosterom, D., van Agteren, M., & van de Wetering, J. (2007) · Journal of Nephrology · doi:10.1093/joneph/20.5.602 · Cited by 128
Citrate clearance in children receiving continuous venovenous renal replacement therapy
Chadha, V., Garg, U. C., Warady, B. A., & Alon, U. S. (2002) · Pediatric Nephrology · doi:10.1007/s00467-002-0963-6 · Cited by 113
Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge
Gabutti, L., Marone, C. C., Colucci, G., Duchini, F., & Schönholzer, C. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1443-y · Cited by 112
Joannidis, M., Kountchev, J., Rauchenzauner, M., Schusterschitz, N., Ulmer, H., Mayr, A. J., & Bellmann, R. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0719-7 · Cited by 101
Cp, S., Hk, V. S., Dr, M., & Zandstra, D. F. (1983) · PubMed · Cited by 72
Self-citationBorawski, J. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.001 · Cited by 53
Isla, A., Rodríguez‐Gascón, A., Maynar, J., Arzuaga, A., Corral, E., Martín, A. H. S., Solinís, M. Á., & Pedraz, J. L. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.09.008 · Cited by 31
Cited by
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
Khwaja, A. (2012) · Nephron Clinical Practice · doi:10.1159/000339789 · Cited by 8,014
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
Frontera, J. A., Lewin III, J. J., Rabinstein, A. A., Aisiku, I. P., Alexandrov, A. W., Cook, A. M., del Zoppo, G. J., Kumar, M. A., Peerschke, E. I. B., Stiefel, M. F., et al. (2016) · Neurocritical Care · doi:10.1007/s12028-015-0222-x · Cited by 706
Zarbock, A., Küllmar, M., Kindgen-Milles, D., Wempe, C., Gerss, J., Brandenburger, T., Dimski, T., Tyczynski, B., Jahn, M., Mülling, N., et al. (2020) · JAMA · doi:10.1001/jama.2020.18618 · Cited by 366
Continuous Renal Replacement Therapy
Tandukar, S., & Palevsky, P. M. (2019) · Chest · doi:10.1016/j.chest.2018.09.004 · Cited by 336
Metadata
- Authors
- Oudemans-van Straaten, H. M., Bosman, R. J., Koopmans, M., van der Voort, P. H. J., Wester, J. P. J., van der Spoel, J. I., Dijksman, L. M., & Zandstra, D. F.
- Venue
- Critical Care Medicine
- Published
- 2009-02
- Volume
- 37
- Issue
- 2
- Pages
- 545-552
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W1989567087
- Cited by
- 332
- References
- 33
- FWCI
- 17.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.